BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20054335)

  • 1. Does IVIg administration yield improved immune function in very premature neonates?
    Wynn JL; Seed PC; Cotten CM
    J Perinatol; 2010 Oct; 30(10):635-42. PubMed ID: 20054335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulation, part III: intravenous immunoglobulin.
    Bell SG
    Neonatal Netw; 2006; 25(3):213-21. PubMed ID: 16749376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential modulation of cord blood and peripheral blood monocytes by intravenous immunoglobulin.
    Gille C; Dreschers S; Spring B; Tárnok A; Bocsi J; Poets CF; Orlikowsky TW
    Cytometry B Clin Cytom; 2012 Jan; 82(1):26-34. PubMed ID: 21812105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preterm infants with low immunoglobulin G levels have increased risk of neonatal sepsis but do not benefit from prophylactic immunoglobulin G.
    Sandberg K; Fasth A; Berger A; Eibl M; Isacson K; Lischka A; Pollak A; Tessin I; Thiringer K
    J Pediatr; 2000 Nov; 137(5):623-8. PubMed ID: 11060526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter randomized placebo controlled trial of therapy with intravenous immunoglobulin in decreasing mortality due to neonatal sepsis.
    Shenoi A; Nagesh NK; Maiya PP; Bhat SR; Subba Rao SD
    Indian Pediatr; 1999 Nov; 36(11):1113-8. PubMed ID: 10745332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulin in the prevention and treatment of neonatal bacterial sepsis.
    Lassiter HA
    Adv Pediatr; 1992; 39():71-99. PubMed ID: 1442320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged intravenous immunoglobulin treatment in very low birth weight infants with late onset sepsis.
    Bancalari A; Muñoz T; Martínez P
    J Neonatal Perinatal Med; 2020; 13(3):381-386. PubMed ID: 31771081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of immunoglobulin therapy on phagocytosis by polymorphonuclear leucocytes in whole blood of neonates.
    Fujiwara T; Taniuchi S; Hattori K; Kobayashi T; Kinoshita Y; Kobayashi Y
    Clin Exp Immunol; 1997 Mar; 107(3):435-9. PubMed ID: 9067513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulins induce potentially synergistic immunomodulations in autoimmune disorders.
    Imbach P; Lazarus AH; Kühne T
    Vox Sang; 2010 Apr; 98(3 Pt 2):385-94. PubMed ID: 19821958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody therapy (IVIG): evaluation of the use of genomics and proteomics for the study of immunomodulation therapeutics.
    Sapan CV; Reisner HM; Lundblad RL
    Vox Sang; 2007 Apr; 92(3):197-205. PubMed ID: 17348868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose of intravenous immunoglobulin modulates immune tolerance in premature infants.
    Liu P; Li L; Fan P; Zheng J; Zhao D
    BMC Pediatr; 2018 Feb; 18(1):74. PubMed ID: 29466960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal and postnatal prophylaxis of infections in preterm neonates.
    von Muralt G; Sidiropoulos D
    Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S72-8. PubMed ID: 3135529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preventive and therapeutic use of intravenous administration of immunoglobulins in intensive care patients in pediatrics].
    Leititis JU
    Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():29-34. PubMed ID: 8499748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of intravenous immune globulin in newborn infants.
    Fischer GW
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):73-7. PubMed ID: 8033439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulins and haematopoietic growth factors in the prevention and treatment of neonatal sepsis: ground reality or glorified myths?
    Shaw CK; Thapalial A; Shaw P; Malla K
    Int J Clin Pract; 2007 Mar; 61(3):482-7. PubMed ID: 17313617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analyses of the effectiveness of intravenous immune globulin for prevention and treatment of neonatal sepsis.
    Jenson HB; Pollock BH
    Pediatrics; 1997 Feb; 99(2):E2. PubMed ID: 9099759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum levels of IgG subclasses in critically ill premature infants treated with intravenous immunoglobulins].
    Puccio VF; Soliani M; Corea D; Puncuh F; Massone ML; Nahum L; Pisano F; Castellani R; Cornaglia-Ferraris P
    Minerva Pediatr; 1991 Oct; 43(10):637-44. PubMed ID: 1758385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immune globulin therapy for early-onset sepsis in premature neonates.
    Weisman LE; Stoll BJ; Kueser TJ; Rubio TT; Frank CG; Heiman HS; Subramanian KN; Hankins CT; Anthony BF; Cruess DF
    J Pediatr; 1992 Sep; 121(3):434-43. PubMed ID: 1517923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin subclass concentration in preterm infants treated prophylactically with different intravenous immunoglobins.
    Amato M; Hüppi P; Imbach P; Llauto A; Bürgi W
    Am J Perinatol; 1995 Sep; 12(5):306-9. PubMed ID: 8540928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the neonatal immune system: high risk for infection.
    McKenney WM
    Crit Care Nurse; 2001 Dec; 21(6):35-47. PubMed ID: 11767763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.